• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by American Vanguard Corporation

    5/12/25 4:15:09 PM ET
    $AVD
    Agricultural Chemicals
    Industrials
    Get the next $AVD alert in real time by email
    NT 10-Q 1 d926499dnt10q.htm NT 10-Q NT 10-Q
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 12b-25

     

     

    NOTIFICATION OF LATE FILING

     

    (Check One)   

    ☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q

    ☐ Form 10-D  ☐ Form N-SAR  ☐ Form N-CSR

      For Period Ended: March 31, 2025
      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
      ☐ Transition Report on Form N-SAR
      For the Transition Period Ended:  

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

       

     

    PART I — REGISTRANT INFORMATION

    AMERICAN VANGUARD CORPORATION

    4695 MacArthur Court

    Suite 1200

    Newport Beach, California 92660

    PART II — RULES 12b-25(b) AND (c)

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    ☒     (a)   The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     

     

    (b)

     

     

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

     

    (c)

     

     

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

    PART III — NARRATIVE

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    American Vanguard Corporation (the “Company”) is unable to file, without unreasonable effort or expense, its Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”) by May 12, 2025, the original due date for such filing. Specifically, the Company requires additional time and effort to complete certain documentation, disclosures and analyses to be included either in, or in support of, the Company’s Annual Report on Form 10-K. for the fiscal year ended December 31, 2024 (the “Form 10-K”) and, therefore, the Form 10-Q which will be filed subsequent to the Form 10-K. The Company expects to file the Form 10-K and then the Form 10-Q within the 5 calendar day extension period provided for the Form 10-Q by Rule 12b-25 under the Securities Exchange Act of 1934, as amended.

    (Attach Extra Sheets if Needed)

    PART IV — OTHER INFORMATION

     

    (1)       Name and telephone number of person to contact in regard to this notification
        Timothy J. Donnelly         949         221-6115
        (Name)     (Area Code)     (Telephone Number)
    (2)     Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☐ Yes ☒ No Annual Report on Form 10-K for the fiscal year ended December 31, 2024
         
    (3)     Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No
        If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

    Forward-Looking Statements

    The Company’s statements included in this Form 12b-25 include forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, and actual events may differ materially from those contemplated by these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties, including the inability of the Company to complete the work necessary in order to file the 2024 Form 10-K in the time frame that is anticipated. The Company undertakes no obligation to revise or update any forward-looking statements to reflect actual events or circumstances after the date hereof.

    American Vanguard Corporation

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    May 12, 2025        By  

    /s/ Timothy J. Donnelly

          Timothy J. Donnelly
          CIO, General Counsel & Secretary

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

     

    ATTENTION

     

    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

     

     
     
    Get the next $AVD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVD

    DatePrice TargetRatingAnalyst
    7/22/2024$14.00Buy
    Lake Street
    More analyst ratings

    $AVD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottschalk Patrick E acquired 47,281 shares, increasing direct ownership by 60% to 126,705 units (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    12/1/25 7:37:09 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    Director Rosenbloom Keith M disposed of 217,503 shares (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    12/1/25 6:52:26 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    Director Bassett Mark R acquired 23,636 shares, increasing direct ownership by 69% to 58,047 units (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    12/1/25 6:37:58 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on American Vanguard with a new price target

    Lake Street initiated coverage of American Vanguard with a rating of Buy and set a new price target of $14.00

    7/22/24 8:25:03 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    SEC Filings

    View All

    American Vanguard Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AMERICAN VANGUARD CORP (0000005981) (Filer)

    11/12/25 7:24:53 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    SEC Form 10-Q filed by American Vanguard Corporation

    10-Q - AMERICAN VANGUARD CORP (0000005981) (Filer)

    11/10/25 8:54:37 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure

    8-K - AMERICAN VANGUARD CORP (0000005981) (Filer)

    8/19/25 4:34:15 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    American Vanguard Reports Second Quarter 2025 Results

    Quarterly Adjusted EBITDA of $11 million vs. $6 million in 2Q last year Gross Profit Margin improved to 31% as compared to 29% in 2Q last year Reiterates 2025 revenue and EBITDA guidance American Vanguard® Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter ended June 30, 2025. Financial and Operational Highlights Second Quarter 2025– versus Second Quarter 2024: Net sales of $129 million v. $128 million; Adjusted EBITDA1 of $11 million v. $6 million; Maint

    7/31/25 4:12:00 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Announces Date of Second Quarter 2025 Earnings Release and Webcast Conference Call

    American Vanguard® Corporation (NYSE:AVD) announced today it will release financial results for the second quarter of 2025 on Thursday, July 31, 2025, after the market closes. The company will conduct a conference call focusing on operating performance and financial results at 5:00 p.m. ET / 2:00 p.m. PT on Thursday, July 31, 2025. The conference call will be webcast live, available in the Investors section of the Company's website at www.american-vanguard.com or through the following link: https://www.webcaster4.com/Webcast/Page/3070/52784 If you are unable to listen live, the conference call will be archived on the Company's website: www.american-vanguard.com/investors About America

    7/30/25 12:24:00 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Announces Voting Results of 2025 Annual Meeting of Stockholders

    American Vanguard Corporation (NYSE:AVD) announced the voting results from its Annual Meeting of Stockholders held on July 2, 2025. As to the first of three initiatives, the nine director nominees named in the proxy received more votes "for" than "against"; those persons are: Marisol Angelini, Scott Baskin, Mark Bassett, Patrick Gottschalk, Emer Gunter, Douglas Kaye, Steven Macicek, Keith Rosenbloom and Carmen Tiu. They will serve as directors until the next annual meeting or until their successors are duly elected and qualified. In addition, the balance of the initiatives appearing on the Company's proxy passed, namely, the ratification of the appointment of Deloitte Touche, LLP as the com

    7/7/25 9:00:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Kaye Douglas bought $9,340 worth of shares (2,000 units at $4.67), increasing direct ownership by 0.69% to 290,461 units (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    6/12/25 6:13:45 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    Director Macicek Steven D bought $71,640 worth of shares (12,000 units at $5.97), increasing direct ownership by 62% to 31,218 units (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    11/18/24 7:54:49 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    Director Rosenbloom Keith M bought $790,844 worth of shares (136,492 units at $5.79) (SEC Form 4)

    4 - AMERICAN VANGUARD CORP (0000005981) (Issuer)

    9/5/24 2:20:02 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Leadership Updates

    Live Leadership Updates

    View All

    American Vanguard Announces Voting Results of 2025 Annual Meeting of Stockholders

    American Vanguard Corporation (NYSE:AVD) announced the voting results from its Annual Meeting of Stockholders held on July 2, 2025. As to the first of three initiatives, the nine director nominees named in the proxy received more votes "for" than "against"; those persons are: Marisol Angelini, Scott Baskin, Mark Bassett, Patrick Gottschalk, Emer Gunter, Douglas Kaye, Steven Macicek, Keith Rosenbloom and Carmen Tiu. They will serve as directors until the next annual meeting or until their successors are duly elected and qualified. In addition, the balance of the initiatives appearing on the Company's proxy passed, namely, the ratification of the appointment of Deloitte Touche, LLP as the com

    7/7/25 9:00:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Appoints Industry Veteran, Douglas A. ("Dak") Kaye, III as Chief Executive Officer

    Well-positioned to further accelerate transforming the global Company into an efficient, profitable, customer-centric organization American Vanguard® Corporation (AVD), a leading manufacturer and marketer of innovative solutions for the ag industry in the areas of crop protection and nutrition, turf and ornamental management, and commercial pest control (the "Company"), today announced the appointment of Douglas A. ("Dak") Kaye, III as the new Chief Executive Officer following a unanimous vote from its Board of Directors (the "Board"), effective December 9, 2024. Mr. Kaye will be based at global headquarters beginning January 6, 2025. Mr. Kaye brings extensive experience to AVD and is exp

    12/5/24 9:00:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Announces Voting Results of Its 2024 Annual Meeting of Stockholders

    American Vanguard Corporation (NYSE:AVD) today announced voting results from its Annual Meeting of Stockholders held on June 6, 2024. As to the first of three initiatives, the nine director nominees named in the proxy received more votes "for" than "against"; those persons are, Marisol Angelini, Scott Baskin, Mark Bassett, Debra Edwards, Emer Gunter, Patrick Gottschalk, Steven Macicek, Keith Rosenbloom and Eric Wintemute. They will serve as directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified. In addition, the balance of the initiatives appearing on the Company's proxy passed, namely, the ratification of the appointment of Deloitte

    6/11/24 9:00:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Financials

    Live finance-specific insights

    View All

    American Vanguard Reports Second Quarter 2025 Results

    Quarterly Adjusted EBITDA of $11 million vs. $6 million in 2Q last year Gross Profit Margin improved to 31% as compared to 29% in 2Q last year Reiterates 2025 revenue and EBITDA guidance American Vanguard® Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter ended June 30, 2025. Financial and Operational Highlights Second Quarter 2025– versus Second Quarter 2024: Net sales of $129 million v. $128 million; Adjusted EBITDA1 of $11 million v. $6 million; Maint

    7/31/25 4:12:00 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Announces Date of Second Quarter 2025 Earnings Release and Webcast Conference Call

    American Vanguard® Corporation (NYSE:AVD) announced today it will release financial results for the second quarter of 2025 on Thursday, July 31, 2025, after the market closes. The company will conduct a conference call focusing on operating performance and financial results at 5:00 p.m. ET / 2:00 p.m. PT on Thursday, July 31, 2025. The conference call will be webcast live, available in the Investors section of the Company's website at www.american-vanguard.com or through the following link: https://www.webcaster4.com/Webcast/Page/3070/52784 If you are unable to listen live, the conference call will be archived on the Company's website: www.american-vanguard.com/investors About America

    7/30/25 12:24:00 PM ET
    $AVD
    Agricultural Chemicals
    Industrials

    American Vanguard Reports First Quarter 2025 Results

    Substantially Reduced Operating Expenses Materially Decreased Net Working Capital Consumption Industry In the Early Innings of a Recovery American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2025. Financial and Operational Highlights – First Quarter 2025 versus First Quarter 2024: Net sales of $115.8 million v. $135.1 million; Adjusted EBITDA1 of $3.0 million v. $15.5 million; EPS of $(0.30) v. $0.06 Other Oper

    6/6/25 6:15:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    $AVD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by American Vanguard Corporation

    SC 13G/A - AMERICAN VANGUARD CORP (0000005981) (Subject)

    11/14/24 7:00:30 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by American Vanguard Corporation

    SC 13G/A - AMERICAN VANGUARD CORP (0000005981) (Subject)

    10/31/24 11:54:57 AM ET
    $AVD
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by American Vanguard Corporation

    SC 13G - AMERICAN VANGUARD CORP (0000005981) (Subject)

    7/11/24 10:46:25 AM ET
    $AVD
    Agricultural Chemicals
    Industrials